血清半乳甘露聚糖检测对血液肿瘤患者侵袭性曲霉病诊断价值的评估

姜华, 贺兆斌, 袁代, 等. 血清半乳甘露聚糖检测对血液肿瘤患者侵袭性曲霉病诊断价值的评估[J]. 临床血液学杂志, 2012, 25(3): 163-168. doi: 10.13201/j.issn.1004-2806.2012.02.001
引用本文: 姜华, 贺兆斌, 袁代, 等. 血清半乳甘露聚糖检测对血液肿瘤患者侵袭性曲霉病诊断价值的评估[J]. 临床血液学杂志, 2012, 25(3): 163-168. doi: 10.13201/j.issn.1004-2806.2012.02.001
JIANG Hua, HE Zhaobin, YUAN Dai, et al. Cinical value of serum galactomannan detection for invasive aspergillosis patients with hematologic disease/cancer[J]. J Clin Hematol, 2012, 25(3): 163-168. doi: 10.13201/j.issn.1004-2806.2012.02.001
Citation: JIANG Hua, HE Zhaobin, YUAN Dai, et al. Cinical value of serum galactomannan detection for invasive aspergillosis patients with hematologic disease/cancer[J]. J Clin Hematol, 2012, 25(3): 163-168. doi: 10.13201/j.issn.1004-2806.2012.02.001

血清半乳甘露聚糖检测对血液肿瘤患者侵袭性曲霉病诊断价值的评估

  • 基金项目:

    山东省科技发展计划项目(No:2008GG2 NS02018)

详细信息
    通讯作者: 王欣,E-mail:xinwang55@yahoo.com.cn
  • 中图分类号: R519.8

Cinical value of serum galactomannan detection for invasive aspergillosis patients with hematologic disease/cancer

More Information
  • 目的:探讨血清半乳甘露聚糖(GM)抗原检测对于血液肿瘤患者侵袭性曲霉病(invasive aspergillosis,IA)的早期诊断和疗效评判的临床意义。方法:选取 127例血液肿瘤并发中性粒细胞减少伴发热、广谱抗生素治疗无效的患者治疗前后的402份血清标本。采用ELISA法进行血清GM浓度测定,同时收集患者的临床资料。评价GM测定对于血液肿瘤患者IA的诊断价值和抗真菌治疗前后GM浓度变化的意义,并进行统计学分析。结果:拟将本观察组血液肿瘤患者并发IA的血清GM检测结果的单次I ≥0.7,或连续2次I ≥0.5做为阳性界值时,本试验的敏感性、特异性、阳性预测值和阴性预测值分别为92.3%、82.4%、57.1%和97.7%,与试剂盒提供的血清GM试验结果的I ≥1.5的阳性界值相比灵敏度提高,而特异性无明显降低,因此能够有效区分临床诊断和拟诊两个IA级别。在其他实验室检测和影像学结果基础上加入GM试验后,临床诊断病例组的人数明显增加。根据我们确定的阳性界值标准,GM实验阳性早于痰培养或涂片平均(6.1±4.5) d(1~11 d);也早于CT影像学证据平均(7.2±5.5) d(1~15 d)。抗真菌治疗有效患者的GM水平随着治疗呈波动性下降,无效患者GM水平无变化。GM浓度与本观察组患者疾病的治疗及预后具有相关性。结论:血清GM抗原检测是早期诊断IA的一种有效方法。将单次I ≥0.7或连续2次I ≥0.5作为阳性界值比单用一种界值敏感性提高,特异性理想。在高危血液肿瘤伴粒细胞缺乏患者中以GM实验阳性为起点抢先抗曲霉菌治疗,可降低IA病死率,监测血清GM浓度的动态变化具有评判疗效的重要价值。
  • 加载中
  • [1]

    FANG B,ZHENG C,LIAO L,et al.Identification of human chronic myelogenous leukemia progenitor cells with hemangioblastic characteristics[J].Blood,2005,105:2733-2740.

    [2]

    WALLACE S R,OKEN M M,LUNETTE K L,et al. Abnormalities of bone marrow mesenchymal cells in multiple myeloma patients[J].Cancer,2002,91:1219-1230.

    [3]

    郭奇峰,刘青华,徐绘华,等. 成人骨髓间充质干细胞的体外分离培养与鉴定[J]. 中华显微外科杂志,2010,33(1):49-51.

    [4]

    李炳宗,史明霞,李静,等.肿瘤坏死因子α对骨髓瘤患者骨髓间充质干细胞TAZ表达和成骨潜能的影响[J].中华肿瘤杂志,2009,31(1):5-9.

    [5]

    MECARTY R C,GRONTHOS S,ZANNETTINO A C,et al.Characterlsation and developmental potential of ovine bone marow derived mesenchymalstem cells[J]. J Cell Physiol,2008,29:381-402.

    [6]

    ZHANG X,YANG M,LIN L,et al.Runx2 over expression enhances osteoblastic diferentiation and mineralization in adipose-derived stem cells in vitro and in vivo[J]. Calcif Tissue Int,2006,79:l69-178.

    [7]

    WESTENDORF J,KAHLER R A,SCHROEDER T M.Wnt signaling in osteoblasts and bone diseases[J].Gene,2004,341,19-39.

    [8]

    MUSTIKA R,BUDIYANTO A,NISHIGORI C,et al. Decreased expression of Apaf-1 with progression of melanoma[J].Pigment Cell Res,2005,18:59-62.

    [9]

    HONG J H,YAFFE M B. TAZ,a Beta-catenin-like molecule that regulates mesenchymal stern cell differentiation[J].Cell Cyc1e,2006,5:176-179.

    [10]

    GAUR T,LENGNER C J,HOVHANNISYAN H,et al. Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression[J].J Biol Chem,2005,280:33132-33140.

  • 加载中
计量
  • 文章访问数:  294
  • PDF下载数:  143
  • 施引文献:  0
出版历程
收稿日期:  2011-07-23

目录